The global strategy on public health, innovation and intellectual property aims to promote new thinking on innovation and access to medicines and, based on the recommendations of the report of the Commission on Intellectual Property Rights, Innovation and Public Health, provide a medium-term framework for securing an enhanced and sustainable basis for needs-driven essential health research and development relevant to diseases that disproportionately affect developing countries, proposing clear objectives and priorities for research and development, and estimating funding needs in this area.
The overall purpose of this comprehensive evaluation was to assess the status of implementation of the eight elements of the global strategy and plan of action, its 25 sub-elements and 108 specific actions. It looked at such implementation by all stakeholders listed in the action plan at different levels (global, regional and national), including national governments, the WHO Secretariat and other relevant stakeholders.
Covering the period 2008–2015, the evaluation documented achievements, gaps and remaining challenges and the evaluators have identified areas for future work and proposed recommendations which the overall programme review, planned for 2017, may wish to consider.
Year Published | |
Type | |
Theme/s | |
Joint | No |
Partner/s | N/A |
SDG/s | |
Consultant name | Capra International Inc. |
Agency Focal Point | Anand Sivasankara Kurup |
Focal Point Email | evaluation@who.int |
Managed by Independent Evaluation Office | Yes |